T1	Condition 18 36	systemic infection
T2	Condition 56 90	human Immunodeficiency virus (HIV)
T3	Condition 92 115	hepatitis B virus (HBV)
T4	Condition 121 144	hepatitis C virus (HCV)
T5	Grammar_Error 117 120	and
*	OR T3 T4 T2
T6	Context_Error 172 222	the medicine which is prohibited during this study
T7	Non-query-able 159 171	need to take
T8	Condition 242 248	asthma
T9	Non-query-able 263 275	can not stop
T10	Drug 291 307	topical steroids
T11	Context_Error 309 318	group 1~5
T12	Drug 321 337	oral antibiotics
T13	Procedure 339 367	whole body photochemotherapy
T14	Drug 369 391	immunosuppressive drug
T15	Temporal 392 413	within 4 weeks before
T16	Reference_point 418 433	treatment visit
R1	Has_index Arg1:T15 Arg2:T16	
T17	Scope 291 391	topical steroids (group 1~5), oral antibiotics, whole body photochemotherapy, immunosuppressive drug
*	OR T10 T12 T13 T14
R2	AND Arg1:T17 Arg2:T9	
R3	Has_temporal Arg1:T9 Arg2:T15	
T18	Condition 435 443	Pregnant
T19	Condition 445 459	breast-feeding
T20	Person 460 465	women
T21	Person 469 474	women
T22	Non-query-able 479 493	plan to become
T23	Condition 494 502	pregnant
R4	AND Arg1:T23 Arg2:T22	
T24	Temporal 503 520	during this study
R5	Has_temporal Arg1:T22 Arg2:T24	
T25	Condition 533 555	childbearing potential
T26	Person 522 529	Females
T27	Measurement 577 597	urine pregnancy test
T28	Value 568 576	negative
R6	Has_value Arg1:T27 Arg2:T28	
A1	Optional T20
A2	Optional T21
A3	Optional T26
A4	Optional T25
R7	AND Arg1:T25 Arg2:T27	
R8	AND Arg1:T26 Arg2:T25	
T29	Scope 435 459	Pregnant, breast-feeding
R9	Has_scope Arg1:T20 Arg2:T29	
R10	AND Arg1:T21 Arg2:T23	
*	OR T20 T21 T26
T30	Non-query-able 600 713	Subjects who currently participate in other clinical trial or participated in other clinical trial within 30 days
T31	Context_Error 600 713	Subjects who currently participate in other clinical trial or participated in other clinical trial within 30 days
T32	Undefined_semantics 734 756	serious adverse events
T33	Condition 734 756	serious adverse events
T34	Temporal 757 763	during
T35	Reference_point 764 781	stem cell therapy
T36	Procedure 764 781	stem cell therapy
R11	Has_index Arg1:T34 Arg2:T35	
R12	Has_temporal Arg1:T33 Arg2:T34	
T37	Condition 802 818	hypersensitivity
T38	Drug 822 833	antibiotics
T39	Drug 837 849	antimycotics
*	OR T38 T39
T40	Scope 822 849	antibiotics or antimycotics
R13	Has_scope Arg1:T37 Arg2:T40	
T41	Measurement 864 874	creatinine
T42	Value 884 942	more than two times of the upper limit of the normal range
T43	Temporal 943 960	at screening test
T44	Reference_point 946 960	screening test
R14	Has_index Arg1:T43 Arg2:T44	
R15	Has_value Arg1:T41 Arg2:T42	
R16	Has_temporal Arg1:T41 Arg2:T43	
T45	Measurement 975 1029	aspartate transaminase/alkaline transaminase (AST/ALT)
T46	Value 1039 1099	more than three times of the upper limit of the normal range
T47	Temporal 1100 1117	at screening test
T48	Reference_point 1103 1117	screening test
R17	Has_temporal Arg1:T45 Arg2:T47	
R18	Has_value Arg1:T45 Arg2:T46	
R19	Has_index Arg1:T47 Arg2:T48	
T49	Condition 1137 1156	any other condition
T50	Qualifier 1163 1241	the investigator judges would make patients unsuitable for study participation
T51	Subjective_judgement 1163 1241	the investigator judges would make patients unsuitable for study participation
T52	Undefined_semantics 1163 1241	the investigator judges would make patients unsuitable for study participation
T53	Context_Error 1163 1241	the investigator judges would make patients unsuitable for study participation
R20	Has_qualifier Arg1:T49 Arg2:T50	
